The Tiny Cargo Company is a biotechnology company transforming drug delivery through milk-derived exosomes. Our platform harnesses these naturally evolved nanovesicles to transport peptides, monoclonal antibodies, small molecules, cosmeceutical actives and nutraceutical compounds, safely and efficiently across multiple routes of administration.

We produce pharmaceutical-grade, cGMP-compliant milk-derived exosomes in kilogram quantities, an industrial leap that enables broad application across oral, topical, and targeted delivery routes. Our exosomes demonstrate >90% loading efficiency, long-term stability as a lyophilized powder, and the unique ability to cross biological barriers - including the gut, brain, and skin without triggering an immune response.

Our manufacturing plant in Roanoke, Virginia, will be the world’s first facility dedicated to large-scale production of purified milk-derived exosomes for pharmaceutical, cosmeceutical, and nutraceutical use. By upcycling existing dairy materials, we offer a sustainable, high-purity, and commercially viable supply chain providing biologically compatible delivery vehicles that meet commercial demand.

At Tiny Cargo, we are shaping the future of delivery by integrating evolutionary biology with scalable manufacturing, enabling complex therapeutics, advanced skincare actives, and health-enhancing nutraceuticals to transition seamlessly from research to real-world impact.

The Tiny Cargo Company

Org chart

Teams

Offices